Evidence map›Paper›PMID 23393147›Full record

ReviewMicrobiology (Reading, England)2013

Streptococcus mutans: a new Gram-positive paradigm?

José A Lemos, Robert G Quivey, Hyun Koo, Jacqueline Abranches

Abstract readReview
In one paragraph

Review in Microbiology (Reading, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. AJournal of bacteriology · 2026
    Review
  9. Article
  10. Raman signatures ofFrontiers in microbiology · 2026
    Article
  11. Raman signatures ofFrontiers in microbiology · 2026
    Article
  12. Review
  13. An efficient electrotransformation method for three Bacillus species.Applied microbiology and biotechnology · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

José A LemosCenter for Oral Biology and Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Robert G QuiveyCenter for Oral Biology and Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Hyun KooCenter for Oral Biology and Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Jacqueline AbranchesCenter for Oral Biology and Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.

Funding

Role of the Spx Regulator in Streptococcus mutansR01DE019783 · NIDCR · UNIVERSITY OF ROCHESTER · PI LEMOS, JOSE A · 2010 to 2020
$3.7M
Fitness profiling of the Streptococcus mutans genomeR01DE017425 · NIDCR · UNIVERSITY OF ROCHESTER · PI QUIVEY, ROBERT G · 2007 to 2011
$3.5M
Evaluation of a Novel Anti-Caries Approach to Modulate Virulence of S. mutansR01DE018023 · NIDCR · UNIVERSITY OF ROCHESTER · PI KOO, HYUN · 2008 to 2019
$3.4M
Molecular Basis for Caries Inhibiting Effects of Cranberry FlavonoidsR01DE016139 · NIDCR · UNIVERSITY OF ROCHESTER · PI KOO, HYUN · 2004 to 2014
$2.5M
VIRULENCE AND GENETIC RECOMBINATION OF ORAL STREPTOCOCCIR01DE010174 · NIDCR · UNIVERSITY OF ROCHESTER · PI QUIVEY, ROBERT G · 1996 to 2005
$1.5M
NIDCR NIH HHS DE010174NIDCR NIH HHS DE017425NIDCR NIH HHS DE019783NIDCR NIH HHS DE16139NIDCR NIH HHS DE18023NIDCR NIH HHS R01 DE010174NIDCR NIH HHS R01 DE016139NIDCR NIH HHS R01 DE017425NIDCR NIH HHS R01 DE018023NIDCR NIH HHS R01 DE019783
6 · The paper itself

Abstract

Despite the enormous contributions of the bacterial paradigms Escherichia coli and Bacillus subtilis to basic and applied research, it is well known that no single organism can be a perfect representative of all other species. However, given that some bacteria are difficult, or virtually impossible, to cultivate in the laboratory, that some are recalcitrant to genetic and molecular manipulation, and that others can be extremely dangerous to manipulate, the use of model organisms will continue to play an important role in the development of basic research. In particular, model organisms are very useful for providing a better understanding of the biology of closely related species. Here, we discuss how the lifestyle, the availability of suitable in vitro and in vivo systems, and a thorough understanding of the genetics, biochemistry and physiology of the dental pathogen Streptococcus mutans have greatly advanced our understanding of important areas in the field of bacteriology such as interspecies biofilms, competence development and stress responses. In this article, we provide an argument that places S. mutans, an organism that evolved in close association with the human host, as a novel Gram-positive model organism.

Indexed as

BiofilmsDNA Transformation CompetenceHumansStreptococcus mutansStress, Physiological

Identifiers

PMID23393147
PMCPMC4083656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.